Guideline adherence and patient satisfaction in the treatment of inflammatory bowel disorders - An evaluation study

BMC Health Services Research

Volumn 9, Issue 1, 2009, Pages

  Pieper, Claudia ^a   Haag, Sebastian ^a   Gesenhues, Stefan ^a   Holtmann, Gerald ^b   Gerken, Guido ^a   Jöckel, Karl Heinz ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CROHN DISEASE; CROSS-SECTIONAL STUDY; EVALUATION; FEMALE; GERMANY; HEALTH CARE QUALITY; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; PATIENT SATISFACTION; PRACTICE GUIDELINE; QUALITY OF LIFE; STANDARD; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; GERMANY; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PHYSICIAN'S PRACTICE PATTERNS; QUALITY OF HEALTH CARE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 60849119856     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-9-17     Document Type: Article

References (19)

1. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European collaborative study on inflammatory bowel disease (EC-IBD). S Shivanada J Lennard-Jones R Logan N Fear A Price L Carpenter M van Blankenstein the EC-IBD Study Group, Gut 1996 39 690 7 9014768 10.1136/gut.39.5.690
2. Diseases of the Colon, Rectum, & Anal Canal. JB Kirsner R Shorter, Baltimore: Williams & Wilkins 1994
3. Survival and cause-specific mortality in patients with inflammatory bowel disease: a long-term outcome study in Olmsted County, Minnesota, 1940-2004. T Jess EV Loftus WS Harmsen AR Zinsmeister WJ Tremaine J Melton P Munkholm WJ Sandborn, Gut 2006 55 1248 1254 10.1136/gut.2005.079350 16423890
4. Health-related concerns of people who receive psychological support for inflammatory bowel disease. RG Maunder EC de Rooy BB Toner GR Greenberg AH Steinhart RS McLeod Z Cohen, Can J Gastroenterol 1997 11 8 681 685 9459048
5. Costs of ambulant care for patients with inflammatory bowel disease in general. A Beiche HH Konig M Ebinger D Matysiak-Klose V Braun R Leidl, Z Gastroenterol 2003 41 527 536 10.1055/s-2003-39647 12806538
6. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. A Bassi S Dodd PR Williamson K Bodger, Gut 2004 53 1471 1478 15361497 10.1136/gut.2004.041616
7. The state of the art in the management of inflammatory bowel disease. SB Hanauer DH Present, Rev Gastroenterol Disord 2003 3 81 92 12776005
8. Are Patients with Irritable Bowel Disease receiving optimal care. SI Reddy S Friedman JJ Telford L Strate R Ookubo PA Banks, Am J Gastroenterol 2005 100 1357 1361 10.1111/j.1572-0241.2005.40849.x 15929770
9. Der Bundes-Gesundheitssurvey 1997/98. Das Gesundheitswesen. BM Bellach H Knopf W Thefeld, Sonderheft (Stuttgart Thieme) 1998 60 59 68
10. SF-36 Fragebogen zum Gesundheitszustand. Handanweisung. M Bullinger I Kirchberger, Göttingen: Hogrefe 1998
11. Anxiety and depression in the general population: Normal values in the Hospital Anxiety and Depression Scale. A Hinz R Schwarz, Psychother Psychosom Med Psychol 2001 51 5 193 200 10.1055/s-2001-13279 11417357
12. Self-rating of pain in nonulcer dyspepsia. A methodological study comparing a new fixed-point scale and the visual analogue scale. O Nyrén HO Adami S Bates R Bergström S Gustavsson L Lööf PO Sjödén, J Clin Gastroenterol 1987 9 408 414 3655274
13. Ergebnisse einer evidenzbasierten Konsensuskonferenz der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten zusammen mit dem Kompetenznetz chronisch entzündliche Darmerkrankungen. JC Hoffmann M Zeitz SC Bischoff HJ Brambs HP Bruch HJ Buhr A Dignass I Fischer W Fleig UR Folsch K Herrlinger W Hohne G Jantschek B Kaltz KM Keller U Knebel AJ Kroesen W Kruis H Matthes G Moser S Mundt C Pox M Reinshagen A Reissmann J Riemann G Rogler W Schmiegel J Scholmerich S Schreiber O Schwandner HK Selbmann EF Stange M Utzig C Wittekind, Z Gastroenterol 2004 42 979 983 10.1055/s-2004-813510 15455267
14. Psychosocial factors in ulcerative colitis and crohn s disease. DA Drossmann, Inflammatory Bowel Disease Philadelphia, London, Toronto, Sydney. Saunders, Kirsner JB, 2000 342 357
15. Morbus Crohn, Psychosomatik. Konsensus der Deutschen Gesellschaft und Verdauungs- und Stoffwechselkrankheiten. G Moser DGVS Leitlinien der, Z Gastroenterol 2003 41 50 51 10.1055/s-2003-36668 12541174
16. Effects of mind-body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis. S Elsenbruch J Langhorst K Popkirowa T Müller R Luedtke U Franken A Paul G Spahn A Michalsen OE Janssen M Schedlowski GJ Dobos, Psychotherapy & Psychosomatic 2005 74 277 287 10.1159/000086318
17. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease-a long-term follow-up. DC Baumgart JP Pintoffl A Sturm B Wiedenmann AU Dignass, Am J Gastroenterol 2006 101 5 1048 56 10.1111/j.1572-0241.2006.00524.x 16573777
18. Klinische Studien in Deutschland. Der niedergelassene Gastroenterologe als Partner in klinischen Studien. B Bokemeyer, Dtsch med Wochenschr 2004 129 764 766 10.1055/s-2004-822867 15042496
19. Impact of health care system on physicians' discontent. M Magee M Hojat, J Community Health 2001 26 5 357 65 10.1023/A:1010415301511 11554499